2018 round up in myeloma

The field of multiple myeloma is advancing at a significant pace and 2018 saw the approval of practice-changing new drug combinations and results from pioneering clinical trials. This short infographic video covers the most important advances of the year, insights from experts and highlights some key campaigns and fundraising activities.

UK/NP/1806/0035(1)o - February 2019

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.